Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Watch
Expert ConversationsNews & AnalysisShows & Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
Conferences
Conference CoverageConference ListingPost Conference Perspectives
More
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Pulmonary Fibrosis
  • Rheumatology
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

Rohit Chaudhary, MIS

Advertisement

Articles by Rohit Chaudhary, MIS

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

ByRohit Chaudhary, MIS,Thomas Kingsley, MD,Sauradeep Sarkar, MD,Joseph Carrington, DO,Galo M. Sanchez Palacios, MD,Tushar Sharma, MD,Jalaj Garg, MD,Rahul Chaudhary, MD, MBA
November 10th 2020

The authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.

Six Sigma Approach to Reduce Door-to-Balloon Time for Patients With STEMI

ByTushar Sharma, MD,Rohit Chaudhary, MIS,Jalaj Garg, MD,Ashok Kondur, MD,Divyanshu Mohananey, MD,Rahul Chaudhary, MD
May 5th 2020

Specific measures using a Six Sigma approach led to sustained reduction of door-to-balloon times among patients with ST-segment elevation myocardial infarction (STEMI) in a community setting.

Advertisement

Latest Updated Articles

  • Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting
    Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

    November 10th 2020

  • Six Sigma Approach to Reduce Door-to-Balloon Time for Patients With STEMI
    Six Sigma Approach to Reduce Door-to-Balloon Time for Patients With STEMI

    May 5th 2020



Advertisement
Advertisement

Trending on AJMC

1

US Employer Health Care Costs Projected to Rise 9.5% in 2027

2

FDA Clears First Single-Biomarker Blood Test for Alzheimer

3

FDA Approves Nipocalimab-aahu as First Treatment for wAIHA

4

Lung Cancer Task Force Maps Research Roadmap to Close Survival Gap

5

Rural Patients Face Gaps in Hospice Access, Care Intensity

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text